The chancellor is weighing plans to hand hundreds of millions of pounds in tax incentives to small businesses in next month's budget as she seeks ways to pitch the government as pro-enterprise to ...

King William V will strip family members of honorific titles, while sordid details about Andrew and Fergie’s dealings with billionaire pedophile Jeffrey Epstein continue to emerge. European Editor at ...

WASHINGTON — Sen. John Fetterman was pressed Wednesday about why he still identifies as a Democrat despite his independent streak — as party brass in Pennsylvania quietly plot his downfall. During a ...

Lawyers, GPs and accountants will reportedly face higher taxes as Rachel Reeves looks to top up the Treasury’s coffers by targeting the wealthy. In her Budget next month, Ms Reeves is expected to ...

Asda sells Leon back to founder after owners accused of ‘destroying’ chain Ukraine war: Kremlin demands collapsed Trump talks Fifteen injured after passenger plane drops in altitude mid-air German ...

Pictured: Emmanuel Macron and Donald Trump. The proposed scheme echoes the US’s citizenship-based tax system - Suzanne Plunkett/Pool Photo via AP France has moved one step closer to adopting a ...

Boston's City Council is floating a proposal to open publicly-owned grocery stores in neighborhoods where supermarkets are scarce. But the plan is drawing sharp criticism from retail analysts and free ...

EXCLUSIVE: The Council’s Justus Lipsius building, where we journalists will spend all day and night covering today’s summit and scarfing steak frites in a subterranean canteen, is gearing up for a ten ...

07:55, Wed, Oct 22, 2025 Updated: 08:02, Wed, Oct 22, 2025 Rachel Reeves is set to launch a £2 billion tax raid on lawyers, GPs and accountants as she battles a £30 billion black hole in the public ...

BENIN CITY – ALL is not well with the All Progressives Congress (APC) in Edo State as there are plans to stop the state chairman of the party, Emperor Jaret Tenebe, from being re-elected. Tenebe took ...

Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now it can celebrate a key trial win for its first drug to gain an FDA approval in ...